Detalhe da pesquisa
1.
Efficacy and safety of tepotinib in Asian patients with advanced NSCLC with MET exon 14 skipping enrolled in VISION.
Br J Cancer
; 130(10): 1679-1686, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38575731
2.
Cost-Effectiveness of Tepotinib Versus Capmatinib for the Treatment of Adult Patients With Metastatic Non-Small Cell Lung Cancer Harboring Mesenchymal-Epithelial Transition Exon 14 Skipping.
Value Health
; 26(4): 487-497, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36503033
3.
Health Utility Analysis of Tepotinib in Patients With Non-Small Cell Lung Cancer Harboring MET Exon 14 Skipping.
Value Health
; 26(8): 1155-1163, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36805576
4.
Diagnostic and economic value of biomarker testing for targetable mutations in non-small-cell lung cancer: a literature review.
Future Oncol
; 18(4): 505-518, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34865516
5.
Modelling the Effectiveness of Tepotinib in Comparison to Standard-of-Care Treatments in Patients with Advanced Non-small Cell Lung Cancer (NSCLC) Harbouring METex14 Skipping in the UK.
Target Oncol
; 19(2): 191-201, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38492157
6.
MET Exon 14 Skipping in NSCLC: A Systematic Literature Review of Epidemiology, Clinical Characteristics, and Outcomes.
Clin Lung Cancer
; 24(6): 483-497, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37451931
7.
Tepotinib in patients with non-small cell lung cancer with high-level MET amplification detected by liquid biopsy: VISION Cohort B.
Cell Rep Med
; 4(11): 101280, 2023 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37944528
8.
Matching-Adjusted Indirect Comparison (MAIC) of Tepotinib with Other MET Inhibitors for the Treatment of Advanced NSCLC with MET Exon 14 Skipping Mutations.
Adv Ther
; 39(7): 3159-3179, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35543963
9.
Cost-consequence analysis of COPD treatment according to NICE and GOLD recommendations compared with current clinical practice in the UK.
BMJ Open
; 12(6): e059158, 2022 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36691251
10.
Budget impact of tepotinib in the treatment of adult patients with metastatic non-small cell lung cancer harboring METex14 skipping alterations in the United States.
J Med Econ
; 24(1): 816-827, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34126842
11.
Inhaled therapies for chronic obstructive pulmonary disease: a systematic review and meta-analysis.
BMJ Open
; 10(9): e036455, 2020 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32994234
12.
Protocol for a systematic literature review and network meta-analysis of the clinical benefit of inhaled maintenance therapies in chronic obstructive pulmonary disease.
BMJ Open
; 9(2): e025048, 2019 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30787090